ClarificationSep 29, 2026, 04:21 PM
NovaBay Pharmaceuticals Investigates Unusual Stock Trading Activity
AI Summary
NovaBay Pharmaceuticals, Inc. (NBY) announced on September 29, 2026, that it became aware of unusual trading activity in its common stock on the NYSE American. The company has made inquiries and stated that it does not believe corrective actions are appropriate. NovaBay Pharmaceuticals is not aware of any material non-public information, pending transactions, or other reasons that would explain the trading activity. The company further confirmed that there have been no material developments in its business and affairs that have not been previously disclosed.
Key Highlights
- NovaBay Pharmaceuticals is investigating unusual trading activity in its common stock on the NYSE American.
- The company has made inquiries and does not believe corrective actions are appropriate.
- NovaBay Pharmaceuticals is not aware of any material non-public information that could be causing the trading activity.
- There have been no material developments in the company's business and affairs not previously disclosed.
Price Impact
More from NBY